Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 12, 2026
TickeronGET DAILY SIGNALS
Park Dental Partners (PARK) Reports Revenue Growth but Margin Pressure in Q3

Park Dental Partners (PARK) Reports Revenue Growth but Margin Pressure in Q3

Key Takeaways

  • Revenue rose 6.0% year over year to $64.9 million, roughly in line with analyst estimates.
  • Diluted EPS (earnings per share) fell to $0.27 from $0.72 a year earlier, while adjusted diluted EPS of $0.57 declined from $1.19.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) slipped 6.2% to $5.0 million as higher salaries and benefits squeezed margins.
  • Same-practice revenue growth slowed to 3.2% from 9.9% in the prior-year quarter.
  • Net income climbed 36.1% to $1.7 million, but nine-month net income fell 50.6% to $2.7 million.
  • The company closed its Village Family Dental acquisition in November, expanding into North Carolina.
  • For more context on the quarter, explore Major News, Today's Price Move, Price Targets, and the latest Forecast for PARK.
  • Looking for automated trade ideas? Explore Trending AI Robots to see AI-driven strategies scanning the market in real time.

Why This Quarter Matters

Park Dental Partners, a dental support organization serving affiliated practices, has leaned on acquisitions for growth since its late-2025 IPO. This report offers a useful check on whether revenue momentum can continue while the company absorbs higher labor costs and the added expenses of being public. I think investors will focus on whether organic same-practice trends can offset the margin impact from rising salaries and benefits. The results also provide an early read on how the recently completed Village Family Dental acquisition could influence the fourth quarter and next year.

Quarterly Results in Detail

For the third quarter ended September 30, 2026, PARK posted revenue of $64.9 million, up 6.0% from $61.3 million a year ago. Net income increased 36.1% to $1.7 million, yet diluted EPS dropped to $0.27 from $0.72, largely due to a higher share count after the IPO. Adjusted diluted EPS came in at $0.57, below the prior-year $1.19 but above consensus. Adjusted EBITDA fell 6.2% to $5.0 million, narrowing the margin to 7.7% from 8.7%. Gross margin declined 280 basis points to 12.6% amid higher salaries and benefits. Same-practice revenue growth eased to 3.2% from 9.9%, while affiliated doctors rose 3.2% to 225. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Reaction

Shares of PARK moved lower after the release, falling roughly 3% to 4% in after-hours and next-day trading. The response appears tied to the margin compression and slower same-practice growth, even though revenue stayed on track. Adjusted EPS beat estimates, but the year-over-year drop in profitability measures and thinner gross margins highlighted ongoing cost pressures from labor, benefits, and public-company overhead. Earlier sentiment had drawn support from a solid second quarter and a bullish price target, yet the softer margin picture seems to have cooled some enthusiasm.

Forward Outlook

Looking ahead, several factors stand out for PARK. The Village Family Dental acquisition, closed in November 2026, brings about 48 doctors and 12 locations in North Carolina and should begin contributing revenue in the fourth quarter and into 2027. Management continues to view M&A as the main growth driver, so the pace and quality of future deals will remain central. Cost trends warrant attention as well. Higher salaries and benefits weighed on margins this quarter, and any further wage pressure could keep profitability constrained. At the same time, same-practice revenue growth slowed to 3.2%, so investors will monitor whether patient volumes and provider productivity can pick up. Balance-sheet flexibility to fund expansion without excessive leverage also matters. None of this is a price forecast, but these fundamentals are worth tracking.

AI Tools in My Research Process

From what I see, tools like Tickeron’s AI Screener can help cut through the noise when comparing companies such as PARK to peers. The platform lets users filter by fundamentals, technical patterns, and performance metrics, which I find useful for spotting comparable opportunities in healthcare services without spending hours on manual screens. It serves as a practical starting point when building out research on names in this space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PARK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for PARK turns positive, indicating new upward trend

PARK saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned positive. In 14 of the 15 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PARK just turned positive on October 28, 2026. Looking at past instances where PARK's MACD turned positive, the stock continued to rise in 5 of 6 cases over the following month. The odds of a continued upward trend are 83%.

PARK moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PARK crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +5.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where PARK advanced for three days, in 45 of 49 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PARK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

PARK broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PARK entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.172) is normal, around the industry mean (204.532). P/E Ratio (-26.472) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.381) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. PARK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PARK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 7%. GRDN experienced the highest price growth at 24%, while BMGL experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was -18%. For the same stocks of the Industry, the average monthly volume growth was 63% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 46
Price Growth Rating: 53
SMR Rating: 66
Profit Risk Rating: 82
Seasonality Score: -6 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Industry
N/A
Address
2200 County Road C West
Phone
+1 651 633-0500
Employees
1212
Web
https://www.parkdentalpartners.com
Interact to see
Advertisement
AMD fell -5.03% to $555.85 in regular-session trading Friday, down -$29.45 from Thursday's close of $585.30, as of 9:42 a.m. ET shortly after the opening bell. No verified company-specific news or fundamental catalyst found: the decline tracks a broad semiconductor pullback and is consistent with profit-taking after a +44.7% rebound from the Nov. 5 close of $404.40, with the stock's typical daily swing running at 3.6%.
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
NBIS fell from $154.69 to $129.12, down -16.53%, with the decline starting in premarket trading and continuing through the regular session. The drop followed Q3 results: revenue of $980.8M (+571% YoY) beat estimates, but management cut 2026 revenue guidance to the low end of its range on third-party capacity delays and raised 2026 capex to roughly $27B, reviving financing and execution fears.
The $290 central target is the arithmetic mean of 12 verified analyst price targets (rounded from roughly $293), with a wide range of about $126 to $410. Shares traded near $155 on the eve of the third-quarter report before falling roughly 17% to 22% after full-year guidance disappointed, widening the gap to the target.
Micron Technology shares dropped -5.16% to $769.42 from a prior close of $811.30, with the slide extending into the regular session after a sharp premarket decline. The drop was driven by a broad semiconductor selloff after NVIDIA announced CEO Jensen Huang resigned effective immediately (CFO Colette Kress named interim CEO), hitting AI and memory-chip names including Micron.